{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:04:25Z","timestamp":1791259465188,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.pharma.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T07:45:38Z","timestamp":1399362338000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dosage de l\u2019HbA1c et des produits d\u2019Amadori en biologie humaine"],"prefix":"10.1016","volume":"72","author":[{"given":"P.","family":"Gillery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1515\/cclm-2012-0594","article-title":"Glycemic control in the clinical management of diabetic patients","volume":"51","author":"Mosca","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010\u00a0and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Prac"},{"key":"10.1016\/j.pharma.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/cclm-2012-0548","article-title":"A history of HbA1c through clinical chemistry and laboratory medicine","volume":"51","author":"Gillery","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1373\/clinchem.2010.145201","article-title":"Evaluation of non-enzymatic post-translational modification-derived products as biomarkers of molecular aging of proteins","volume":"56","author":"Jaisson","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0025","series-title":"H\u00e9moglobine glyqu\u00e9e. EMC biologie clinique","author":"Gillery","year":"2009"},{"key":"10.1016\/j.pharma.2014.04.002_bib0030","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/S0021-9258(17)40461-3","article-title":"Structure of carbohydrate of hemoglobin A1c","volume":"252","author":"Koenig","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1515\/CCLM.2007.245","article-title":"Recommendation for the term and measurement unit for \u201cHbA1c\u201d","volume":"45","author":"Nordin","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.diabres.2012.10.007","article-title":"Haemoglobin A1c: historical overview and current concepts","volume":"99","author":"Lenters-Westra","year":"2013","journal-title":"Diabetes Clin Res Pract"},{"key":"10.1016\/j.pharma.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2\u00a0diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2014.04.002_bib0055","first-page":"1083","article-title":"Desirable performance standards for HbA1c analysis\u2013precision, accuracy and standardisation","volume":"45","author":"Goodall","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0060","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/clinchem\/41.11.1644","article-title":"Glycohemoglobin assays evaluated in a large-scale quality control survey","volume":"41","author":"Gillery","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diacare.21.2.265","article-title":"Evaluation of glycohemoglobin assays in France by national quality control surveys","volume":"21","author":"Gillery","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharma.2014.04.002_bib0070","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/dc12-1348","article-title":"Measurement of hemoglobin A1c: a new twist on the path of harmony","volume":"35","author":"Sacks","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharma.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.12.026","article-title":"The long and winding road to optimal HbA1c measurement","volume":"418","author":"Little","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2014.04.002_bib0080","first-page":"5","article-title":"HbA1c standardisation destination\u2013global IFCC standardisation. How, why, where and when: a tortuous pathway from kit manufacturers, via interlaboratory lyophilized and whole blood comparisons to designated national comparison schemes","volume":"26","author":"Goodall","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.pharma.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/clinchem\/44.9.1951","article-title":"What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry","volume":"44","author":"Peterson","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1515\/CCLM.2002.016","article-title":"Approved IFCC reference method for the measurement of HbA1c in human blood","volume":"40","author":"Jeppson","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1373\/clinchem.2007.097402","article-title":"The IFCC reference measurement system for HbA1c: a 6-year progress report","volume":"54","author":"Weykamp","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1373\/clinchem.2003.024802","article-title":"IFCC Working Group on HbA1c standardization: IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study","volume":"50","author":"Hoelzel","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/CCLM.2000.046","article-title":"Influence of in vivo hemoglobin carbamylation on HbA1c values obtained by various methods","volume":"38","author":"Chachou","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2012.12.022","article-title":"Measurement of HbA1c in patients with chronic renal failure","volume":"418","author":"Little","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2014.04.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfu006","article-title":"Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?","author":"Speeckaert","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharma.2014.04.002_bib0120","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc07-9925","article-title":"Consensus statement on the worldwide standardization of the hemoglobin A1c measurement","volume":"30","author":"Consensus Committee. The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharma.2014.04.002_bib0125","first-page":"669","article-title":"Propositions pour l\u2019expression standardis\u00e9e des r\u00e9sultats d\u2019HbA1c","volume":"67","author":"Gillery","year":"2009","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.pharma.2014.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1373\/clinchem.2013.211227","article-title":"Reporting hemoglobin A1c: do the units matter?","volume":"59","author":"Sacks","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(83)90078-5","article-title":"Fructosamine: a new approach to the estimation of serum glycosyl-protein. An index of diabetic control","volume":"127","author":"Johnson","year":"1983","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2014.04.002_bib0140","first-page":"321","article-title":"Standardisation du dosage des fructosamines","volume":"19","author":"Gillery","year":"1993","journal-title":"Diabete Metab"},{"key":"10.1016\/j.pharma.2014.04.002_bib0145","first-page":"1544","article-title":"Pour ne pas renouveler avec la fructosamine les erreurs commises avec le dosage des h\u00e9moglobines glycosyl\u00e9es","volume":"16","author":"Passa","year":"1987","journal-title":"Presse Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0150","first-page":"321","article-title":"Int\u00e9r\u00eats respectifs des dosages d\u2019h\u00e9moglobine glyqu\u00e9e et de fructosamines dans la surveillance du diab\u00e8te sucr\u00e9","volume":"53","author":"Bernard","year":"1995","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.pharma.2014.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2013.04.003","article-title":"Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects","volume":"423","author":"Montagnana","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2014.04.002_bib0160","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1016\/j.bbagen.2013.04.024","article-title":"Clinical, pathophysiological and structure\/function consequences of modification of albumin by Amadori-glucose adducts","volume":"1830","author":"Cohen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharma.2014.04.002_bib0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2008.03202.x","article-title":"Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2\u00a0diabetes","volume":"69","author":"Kumeda","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharma.2014.04.002_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000342055","article-title":"Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2\u00a0diabetic patients","volume":"123","author":"Shen","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.pharma.2014.04.002_bib0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2337\/db13-0782","article-title":"Relationship of glycated albumin to blood-glucose and HbA1c values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT\/EDIC study","volume":"63","author":"Nathan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.pharma.2014.04.002_bib0180","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International expert committee report on the role of the A1c assay in the diagnosis of diabetes","volume":"32","author":"The International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharma.2014.04.002_bib0185","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation","author":"WHO","year":"2011"},{"key":"10.1016\/j.pharma.2014.04.002_bib0190","first-page":"508","article-title":"R\u00e9flexions sur les dosages d\u00e9localis\u00e9s d\u2019h\u00e9moglobine A1c","volume":"26","author":"Bordas-Fonfr\u00e8de","year":"2000","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.pharma.2014.04.002_bib0195","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1373\/clinchem.2013.210781","article-title":"Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices","volume":"59","author":"S\u00f8lvik","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharma.2014.04.002_bib0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jprot.2013.02.015","article-title":"Usefulness of non-enzymatic post-translational modification-derived products (PTMDPs) as biomarkers of chronic diseases","volume":"92","author":"Gillery","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.pharma.2014.04.002_bib0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/cclm-2012-0880","article-title":"Post-translational modification-derived products (PTMDPs): toxins in chronic diseases?","volume":"52","author":"Gillery","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharma.2014.04.002_bib0210","doi-asserted-by":"crossref","first-page":"e65592","DOI":"10.1371\/journal.pone.0065592","article-title":"Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes","volume":"8","author":"Smit","year":"2013","journal-title":"PloS One"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450914000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450914000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:30:45Z","timestamp":1757719845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450914000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0003450914000315"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2014.04.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosage de l\u2019HbA1c et des produits d\u2019Amadori en biologie humaine","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}